1. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, Soerjomataram I. Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast. 2022 Dec 1; 66: 15-23.
2. Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, Jemal A, Siegel RL. Breast cancer statistics, 2022. CA: a cancer journal for clinicians. 2022 Nov; 72(6): 524-41.
3. Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer: Targets and Therapy. 2019 Apr 10: 151-64.
4. Chen J, Douglass J, Prasath V, Neace M, Atrchian S, Manjili MH, Shokouhi S, Habibi M. The microbiome and breast cancer: a review. Breast cancer research and treatment. 2019 Dec; 178: 493-6.
5. Stiemsma LT, Michels KB. The role of the microbiome in the developmental origins of health and disease. Pediatrics. 2018 Apr 1; 141(4).
6. Vijay A, Valdes AM. Role of the gut microbiome in chronic diseases: a narrative. European journal of clinical nutrition. 2022; 76:489-501.
7. Belizário JE, Napolitano M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Frontiers in microbiology. 2015 Oct 6; 6: 1050.
8. Zhang J, Xia Y, Sun J. Breast and gut microbiome in health and cancer. Genes & Diseases. 2021 Sep 1; 8(5): 581-9.
9. Nearing JT, DeClercq V, Langille MG. Investigating the oral microbiome in retrospective and prospective cases of prostate, colon, and breast cancer. npj Biofilms and Microbiomes. 2023 May 1; 9(1): 23.
10. Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G. The microbiota of breast tissue and its association with breast cancer. Applied and environmental microbiology. 2016 Aug 15; 82(16): 5039-48.
11. Salzman NH. The role of the microbiome in immune cell development. Annals of Allergy, Asthma & Immunology. 2014 Dec 1; 113(6): 593-8.
12. Wiertsema SP, van Bergenhenegouwen J, Garssen J, Knippels LM. The interplay between the gut microbiome and the immune system in the context of infectious diseases throughout life and the role of nutrition in optimizing treatment strategies. Nutrients. 2021 Mar; 13(3): 886.
13. Kogut MH, Lee A, Santin E. Microbiome and pathogen interaction with the immune system. Poultry science. 2020 Apr 1; 99(4): 1906-13.
14. Lazar V, Ditu LM, Pircalabioru GG, Gheorghe I, Curutiu C, Holban AM, Picu A, Petcu L,
Chifiriuc MC. Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer. Frontiers in immunology. 2018 Aug 15; 9: 1830.
15. Sun JY, Yin TL, Zhou J, Xu J, Lu XJ. Gut microbiome and cancer immunotherapy. Journal of Cellular Physiology. 2020 May; 235(5): 4082-8.
16. Daneshpour N. Bifidobacterium and the Immune System: A Key Player against Gastrointestinal Cancers. J Microbiota. 2024; 1(3): e154264.
17. Gavzy SJ, Kensiski A, Lee ZL, Mongodin EF, Ma B, Bromberg JS. Bifidobacterium mechanisms of immune modulation and tolerance. Gut Microbes. 2023 Dec 18; 15(2): 2291164.
18. Fernández MF, Reina-Pérez I, Astorga JM, Rodríguez-Carrillo A, Plaza-Díaz J, Fontana L. Breast cancer and its relationship with the microbiota. International journal of environmental research and public health. 2018 Aug; 15(8): 1747.
19. Tzeng A, Sangwan N, Jia M, Liu CC, Keslar KS, Downs-Kelly E, Fairchild RL, Al-Hilli Z, Grobmyer SR, Eng C. Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer. Genome Medicine. 2021 Dec; 13: 1-7.
20. Parida S, Sharma D. The microbiome–estrogen connection and breast cancer risk. Cells. 2019 Dec 15; 8(12): 1642.
21. D’Afonseca V, Muñoz EV, Leal AL, Soto PM, Parra-Cid C. Implications of the microbiome and metabolic intermediaries produced by bacteria in breast cancer. Genetics and Molecular Biology. 2024 Jul 22; 47(Suppl 1): e20230316.
22. Wang T, Chang P, Wang L, Yao Q, Guo W, Chen J, Yan T, Cao C. The role of human papillomavirus infection in breast cancer. Medical Oncology. 2012 Mar; 29: 48-55.
23. Lawson JS, Heng B. Viruses and breast cancer. Cancers. 2010 Apr 30; 2(2): 752-72.
24. Shakir DM, Abdullah SF, Sharquie IK. Serodiagnosis of human herpesvirus 8 in women with breast cancer. Biomedical and Pharmacology Journal. 2018 Mar 25; 11(1): 391-8.
25. Haque S, Raina R, Afroze N, Hussain A, Alsulimani A, Singh V, Mishra BN, Kaul S, Kharwar RN. Microbial dysbiosis and epigenetics modulation in cancer development–A chemopreventive
approach. InSeminars in cancer biology 2022 Nov 1 (Vol. 86, pp. 666-681). Academic Press.
26. Chapadgaonkar SS, Bajpai SS, Godbole MS. Gut microbiome influences incidence and outcomes of breast cancer by regulating levels and activity of steroid hormones in women. Cancer Reports. 2023 Nov; 6(11): e1847.
27. Karpisheh V, Ahmadi M, Abbaszadeh-Goudarzi K, Mohammadpour Saray M, Barshidi A, Mohammadi H, Yousefi M, Jadidi-Niaragh F. The role of Th17 cells in the pathogenesis and treatment of
breast cancer. Cancer Cell International. 2022 Mar 5; 22(1): 108.
28. Zhang N, Ma ZP, Wang J, Bai HL, Li YX, Sun Q, Yang L, Tao L, Zhao J, Cao YW, Li F. Human papillomavirus infection correlates with inflammatory Stat3 signaling activity and IL-17 expression in patients with breast cancer. American journal of translational research. 2016; 8(7): 3214.
29. Hieken TJ, Chen J, Chen B, Johnson S, Hoskin TL, Degnim AC, Walther-Antonio MR, Chia N. The breast tissue microbiome, stroma, immune cells and breast cancer. Neoplasia. 2022 May 1; 27: 100786.
30. Danforth DN. The role of chronic inflammation in the development of breast cancer. Cancers. 2021 Aug 3; 13(15): 3918.
31. Chadha J, Nandi D, Atri Y, Nag A. Significance of human microbiome in breast cancer: Tale of an invisible and an invincible. InSeminars in Cancer Biology 2021 May 1 (Vol. 70, pp. 112-127). Academic Press.
32. Kaur KK, Allahbadia GN. Escalation of Actions of Endocrine Networks for Treating Triple Negative Breast Cancer with Greater Efficacy: A Narrative Review. International Journal of Research in Medical and Clinical Science. 2024 Jul 1; 2(02): 01-19.
33. Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio ME, Jimenez-Rodriguez B, Lavado R, Comino-Méndez I, Alba E, Queipo-Ortuño MI. Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment. Cancers. 2020 Aug 31; 12(9): 2465.
34. Feng K, Ren F, Shang Q, Wang X, Wang X. Association between oral microbiome and breast cancer in the east Asian population: A Mendelian randomization and case – control study. Thoracic Cancer. 2024 Apr; 15(12): 974-86.
35. Tuominen H, Rautava J. Oral microbiota and cancer development. Pathobiology. 2021 Mar 24; 88(2): 116-26.
36. Karpiński TM. Role of oral microbiota in cancer development. Microorganisms. 2019 Jan 13; 7(1): 20.
37. Purchiaroni F, Tortora A, Gabrielli M, Bertucci F, Gigante G, Ianiro G, Ojetti V, Scarpellini E, Gasbarrini A. The role of intestinal microbiota and the immune system. European Review for Medical & Pharmacological Sciences. 2013 Feb 1; 17(3).
38. Kabat AM, Srinivasan N, Maloy KJ. Modulation of immune development and function by intestinal microbiota. Trends in immunology. 2014 Nov 1; 35(11): 507-17.
39. Yang J, Tan Q, Fu Q, Zhou Y, Hu Y, Tang S, Zhou Y, Zhang J, Qiu J, Lv Q. Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications. Breast Cancer. 2017 Mar; 24: 220-8.
40. Kwa M, Plottel CS, Blaser MJ, Adams S. The intestinal microbiome and estrogen receptor–positive female breast cancer. Journal of the National Cancer Institute. 2016 Aug 1; 108(8): djw029.
41. Sharma M, Arora I, Stoll ML, Li Y, Morrow CD, Barnes S, Berryhill TF, Li S, Tollefsbol TO. Nutritional combinatorial impact on the gut microbiota and plasma short-chain fatty acids levels in the prevention of mammary cancer in Her2/neu estrogen receptor-negative transgenic mice. PLoS One. 2020 Dec 31; 15(12): e0234893.
42. McKee AM, Kirkup BM, Madgwick M, Fowler WJ, Price CA, Dreger SA, Ansorge R, Makin KA, Caim S, Le Gall G, Paveley J. Antibiotic-induced disturbances of the gut microbiota results in accelerated breast tumor growth. Iscience. 2021 Sep 24; 24(9).
43. Kaye JA, Jick H. Antibiotics and the Riskof Breast Cancer. Epidemiology. 2005 Sep 1; 16(5): 688-90.
44. Knekt P, Adlercreutz H, Rissanen H, Aromaa A, Teppo L, Heliövaara M. Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer? British journal of cancer. 2000 Mar; 82(5): 1107-10.
45. Ingman WV. The gut microbiome: a new player in breast cancer metastasis. Cancer Research. 2019 Jul 15; 79(14): 3539-41.
46. Eslami-S Z, Majidzadeh-A K, Halvaei S, Babapirali F, Esmaeili R. Microbiome and breast cancer: new role for an ancient population. Frontiers in oncology. 2020 Feb 12; 10: 120.
47. Aarnoutse R, Hillege LE, Ziemons J,
De Vos-Geelen J, de Boer M, Aerts EM, Vriens BE, van Riet Y, Vincent J, van de Wouw AJ, Le GN. Intestinal microbiota in postmenopausal breast
cancer patients and controls. Cancers. 2021 Dec 9; 13(24): 6200.
48. Zeber-Lubecka N, Kulecka M, Jagiełło-Gruszfeld A, Dąbrowska M, Kluska A, Piątkowska M,
Bagińska K, Głowienka M, Surynt P, Tenderenda M, Mikula M. Breast cancer but not the
menopausal status is associated with small changes of the gut microbiota. Frontiers in Oncology. 2024 Jan 24; 14: 1279132.
49. Siddiqui R, Makhlouf Z, Alharbi AM, Alfahemi H, Khan NA. The gut microbiome and female health. Biology. 2022 Nov 21; 11(11): 1683.
50. Mahno NE, Tay DD, Khalid NS, Yassim AS, Alias NS, Termizi SA, Kasian J, Mokhtar NM, Ahmad HF. The Relationship Between Gut Microbiome Estrobolome and Breast Cancer: A Systematic Review of Current Evidences. Indian Journal of Microbiology. 2024 Mar; 64(1): 1-9.
51. Wu AH, Vigen C, Tseng C, Garcia AA, Spicer D. Effect of chemotherapy on the gut microbiome of breast cancer patients during the first year of treatment. Breast Cancer: Targets and Therapy. 2022 Dec 31: 433-51.
52. He S, Li H, Yu Z, Zhang F, Liang S, Liu H, Chen H, Lü M. The gut microbiome and sex
hormone-related diseases. Frontiers in microbiology. 2021 Sep 28; 12: 711137.
53. Klymiuk I, Bilgilier C, Mahnert A, Prokesch A, Heininger C, Brandl I, Sahbegovic H, Singer C, Fuereder T, Steininger C. Chemotherapy-associated oral microbiome changes in breast cancer patients. Frontiers in Oncology. 2022 Aug 9; 12: 949071.
54. Summer M, Sajjad A, Ali S, Hussain T. Exploring the underlying correlation between microbiota, immune system, hormones, and inflammation with breast cancer and the role of probiotics, prebiotics and postbiotics. Archives of Microbiology. 2024 Apr; 206(4): 145.
55. Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nature reviews Gastroenterology & hepatology. 2019 Oct; 16(10): 605-16.
56. Thu MS, Ondee T, Nopsopon T, Farzana IA, Fothergill JL, Hirankarn N, Campbell BJ,
Pongpirul K. Effect of probiotics in breast cancer: a systematic review and meta-analysis. Biology.
2023 Feb 9; 12(2): 280.
57. Malik SS, Saeed A, Baig M, Asif N,
Masood N, Yasmin A. Anticarcinogenecity of microbiota and probiotics in breast cancer. International journal of food properties. 2018 Jan 1; 21(1): 655-66.
58. Toumazi D, El Daccache S, Constantinou C.
An unexpected link: The role of mammary and gut microbiota on breast cancer development
and management. Oncology Reports. 2021 May 1; 45(5): 1-5.
59. Ruo SW, Alkayyali T, Win M, Tara A,
Joseph C, Kannan A, Srivastava K, Ochuba O, Sandhu JK, Went TR, Sultan W. Role of gut microbiota dysbiosis in breast cancer and novel approaches in prevention, diagnosis, and treatment. Cureus. 2021 Aug; 13(8).
